Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy

Healing & Tissue-Repair Peptides

Peptides studied for tendon, ligament, muscle, and gut repair — BPC-157, TB-500, and related regenerative agents.

Healing & Body-Protection Peptides (10)

Ac-SDKP (Thymosin Beta-4 Fragment)
healing body-protection

Ac-SDKP (Thymosin Beta-4 Fragment)

Research-Grade

N-acetyl-seryl-aspartyl-lysyl-proline — a naturally occurring anti-fibrotic tetrapeptide derived from the N-terminus of thymosin beta-4, regulated by ACE and studied for cardiac, renal, and pulmonary fibrosis.

Aib-BPC-157
healing body-protection

Aib-BPC-157

Research-Grade

A modified analog of BPC-157 incorporating alpha-aminoisobutyric acid (Aib) substitutions to enhance proteolytic stability and extend biological half-life while preserving cytoprotective activity.

Angiotensin-(1-7)
healing body-protection

Angiotensin-(1-7)

Research-Grade

A counter-regulatory heptapeptide of the renin-angiotensin system that opposes the vasoconstrictive and pro-inflammatory effects of angiotensin II through the Mas receptor, with cardioprotective, anti-fibrotic, and anti-inflammatory properties.

Apelin
healing body-protection

Apelin

Research-Grade

An endogenous peptide ligand for the APJ receptor (apelin receptor) with potent cardiovascular, angiogenic, and fluid homeostasis functions, studied as a potential therapeutic in heart failure and metabolic disease.

BPC-157
healing body-protection

BPC-157

Research-Grade

A 15-amino-acid peptide fragment derived from gastric juice protein BPC, studied extensively in animal models for tissue healing and gut integrity.

Catestatin
healing body-protection

Catestatin

Research-Grade

A 21-amino-acid endogenous peptide derived from chromogranin A that inhibits catecholamine release via nicotinic acetylcholine receptor antagonism, with cardiovascular protective, antimicrobial, and metabolic regulatory properties under active investigation for hypertension and heart failure.

Larazotide Acetate
healing body-protection

Larazotide Acetate

Pharmaceutical

A synthetic octapeptide tight junction regulator studied in Phase III clinical trials for celiac disease — acts locally in the gut to prevent paracellular permeability increase (leaky gut).

PEGylated BPC-157
healing body-protection

PEGylated BPC-157

Research-Grade

A polyethylene glycol-conjugated variant of BPC-157 engineered for extended half-life and reduced injection frequency while retaining the parent peptide's tissue-healing properties.

TB-500 (Thymosin β4 Fragment)
healing body-protection

TB-500 (Thymosin β4 Fragment)

Research-Grade

Synthetic fragment of Thymosin β4 investigated for actin-binding, cell migration, and tissue repair across muscle, cornea, and cardiac models.

Thymosin Beta-4
healing body-protection

Thymosin Beta-4

Research-Grade

A 43-amino acid peptide and the primary intracellular G-actin sequestering protein. TB-500 is a synthetic fragment of Thymosin Beta-4's active site — this is the full-length parent molecule with broader tissue repair and anti-inflammatory evidence.

Frequently Asked Questions

What is the difference between BPC-157 and TB-500?
They work through different mechanisms and are often combined. BPC-157 modulates the NO system, upregulates growth factor receptors (VEGFR2, FGFR), and promotes angiogenesis — it excels at tendon, ligament, and GI healing in preclinical models. TB-500 (Thymosin Beta-4 fragment) sequesters G-actin to promote cell migration and cytoskeletal remodeling — it addresses the cell-migration component of wound healing. Together, they cover complementary aspects of the repair process.
Do healing peptides work for old injuries or only acute ones?
Most preclinical evidence is in acute injury models. Whether BPC-157 or TB-500 can remodel chronic scar tissue or reverse established tendinopathy is less established. Practitioner reports suggest benefit for chronic conditions, but the biological rationale is weaker — acute healing involves active cellular processes that peptides can amplify, while chronic injuries involve mature scar tissue that may require physical disruption (e.g., PRP, shockwave therapy) before peptides can meaningfully contribute.
Should healing peptides be injected near the injury site?
Local injection near the target tissue provides higher concentration at the injury site and is preferred by most practitioners for musculoskeletal injuries. However, BPC-157 has demonstrated systemic effects in animal models (healing at distant sites from the injection), suggesting subcutaneous injection anywhere may still deliver benefit. For gut-targeted healing, oral BPC-157 is the preferred route since it delivers the peptide directly to the GI mucosa.

Related Product Categories

Browse All peptide Products

Search

Search across products, blog posts, wiki articles, and more.